Global Closed Systems Transfer Devices Market Report Segmented by Type (Needleless, Membrane-to-Membrane), Closing Mechanism (Color-to-Color Alignment, Luer-Lock, Push-to-Turn, Click-to-Lock), Technology (Diaphragm-based, Compartmentalized), End-user (Hospitals, Oncology Centers, ASCs) Forecast to 2031

The global closed systems transfer devices (CSTD) market size is expected to grow at a CAGR of 7% during the forecast period. Increasing use of hazardous drugs in oncology and other therapeutic areas, rising awareness about occupational exposure risks, growing compliance requirements with safety guidelines and NIOSH recommendations, and technological advancements in CSTD design and usability are some of the key driving factors supporting market growth. However, limited adoption in smaller healthcare settings due to the high cost of CSTDs remains a major restraint impacting the growth of the closed systems transfer devices market. To learn more about the research report, download a sample report.

Closed System Transfer Devices (CSTDs) are specialized medical apparatus designed to ensure the safe handling of hazardous drugs by preventing their release into the environment and blocking the entry of contaminants during the preparation and administration of drugs. These devices are essential for protecting healthcare workers, particularly in oncology and other high-risk therapeutic areas, from exposure to harmful drug vapours, aerosols, and spills, ensuring a fully closed controlled system. Recommended by regulatory bodies such as NIOSH and USP , CSTDs are a vital component in promoting workplace safety in healthcare settings. These are available in various types and formats, compatible with diverse drug-delivery systems and designed to support both efficiency and safety in clinical workflows.

To learn more about this report, download the PDF brochure

Rising hazardous drug use and occupational safety concerns drive CSTD adoption in healthcare

The increasing use of hazardous drugs, particularly antineoplastics in oncology and immunosuppressants in other therapeutic areas, is raising serious occupational health concerns. According to NIOSH, over 8 million US healthcare workers risk exposure to these drugs through dermal contact, inhalation, or accidental spills during compounding and administration. These exposures are associated with adverse effects, including infertility, miscarriages, and an increased risk of cancer.

CSTDs mechanically block the release of drug vapors and aerosols, preventing environmental contamination. According to study published by NIH, a longitudinal evaluation over eight months across multiple wards and pharmacy areas using CSTDs plus standard cleaning found surface contamination rates at just 6%, significantly lower than pre-implementation levels. These findings underscore that as hazardous drug use rises, hospitals and infusion centers are increasingly adopting CSTDs, not just as a regulatory requirement but as a proactive measure to safeguard their workforce from long-term exposure and contamination.

Leveraging NIOSH and USP standards to enhance CSTD usability, safety, and engineering controls

Significant technological advancements in the design and usability of CSTDs are being driven by evolving guidelines and testing protocols established by leading authorities such as NIOSH, and USP. NIOSH has developed a draft vapour-containment performance protocol that uses 2-phenoxyethanol (2-POE), a potential compound validated in studies, and highly sensitive analytical methods to evaluate how effectively CSTDs limit hazardous drug vapour release. With the growing awareness of the risk associated with exposure to hazardous drugs, more countries are adopting strict regulatory guidelines, like USP , to continue to reinforce the role of CSTDs as an added layer of protection during hazardous drug handling. These standardized test protocols have influenced manufacturers to enhance mechanical barrier designs, which have led to innovations such as needleless systems, intuitive locking mechanisms (like click-to-lock or color-to-color alignment), and user-friendly assembly, making CSTDs safer and more efficient.

Together, these guidelines have enhanced usability, safety features, and engineering controls across CSTD product lines, aligning device performance more closely with best-practice expectations for healthcare worker protection

To learn more about this report, download the PDF brochure

Recent developments in the closed systems transfer devices market

Recent product launches and evolving regulatory guidelines are reshaping the CSTD technologies, further enhancing occupational safety for healthcare workers. For instance,

• In December 2024, Zephyrus Innovations announced its latest product, VaporShield, which is an injectable closed system transfer device (CSTD) at the Partnership Opportunities in Drug Delivery (PODD) conference in Boston. This device is designed to protect healthcare workers from hazardous drug exposure during subcutaneous or intramuscular injections, addressing needs under USP guidelines
• In October 2023, EQUASHIELD announced that its EQUASHIELD syringe unit has received FDA clearance for full-volume use. The system's closed syringe unit prevents intended and unintended syringe plunger detachmentcan be used safely up to its maximal nominal volume with hazardous drugs
• In March 2022, Simplivia launched Chemfort, a closed-system drug-transfer device presented at the EAHP Conference that features Toxi-Guard air-cleaning technology and a vial-to-vein nursing line to help reduce hazardous-drug exposure during preparation and administration

Competitive Landscape Analysis

The global closed systems transfer devices market comprises of several well-established and emerging players, including Becton, Dickinson and Company; ICU Medical, Inc.; EQUASHIELD LLC; B. Braun Melsungen AG; Baxter International Inc.; JMS Co., Ltd.; Yukon Medical, LLC; Terumo Corporation; West Pharmaceutical Services, Inc.; and Caragen Limited, among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Growth Rate

Report Metric	Details
Base Year Considered	2025
Historical Data	2024 - 2025
Forecast Period	2026 - 2031
7%
Market Drivers	Increasing use of hazardous drugs in oncology and other therapeutic areas Rising awareness about occupational exposure risks Growing compliance requirements with safety guidelines and NIOSH recommendations Increasing adoption in hospitals and oncology centers Rising incidence of chronic diseases requiring long-term drug therapy
Attractive Opportunities	Technological advancements in CSTD design and usability Rising home-based chemotherapy and ambulatory care Growing emphasis on environmental safety
Segment Scope	Type, Closing Mechanism, Technology, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Becton, Dickinson and Company; ICU Medical, Inc.; EQUASHIELD LLC; B. Braun Melsungen AG; Baxter International Inc.; JMS Co., Ltd.; Yukon Medical, LLC; Terumo Corporation; West Pharmaceutical Services, Inc.; and Caragen Limited; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Closed Systems Transfer Devices Market Segmentation

This report by Medi-Tech Insights provides thesize of the global closed systems transfer devices market at theregional- and country-level from 2024 to 2031. The report further segments the market based on type, closing mechanism, technology and end-user.

Market Size & Forecast (2024-2031), By Type, USD Million

• Needleless Systems
• Membrane-to-Membrane Systems

Market Size & Forecast (2024-2031), By Closing Mechanism, USD Million

• Color-to-Color Alignment Systems
• Luer-Lock Systems
• Push-to-Turn Systems
• Click-to-Lock Systems

Market Size & Forecast (2024-2031), By Technology, USD Million

• Diaphragm-based Devices
• Compartmes
• Air Filtration Devices

Market Size & Forecast (2024-2031), By End-user, USD Million

• Hospitals
• Oncology Centers
• ASCs
• Others

Market Size & Forecast (2024-2031), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the closed systems transfer devices market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the closed systems transfer devices market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?